SG Americas Securities’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $9.45M | Buy |
|
|||||
|
2025
Q2 | $781K | Sell |
|
|||||
|
2025
Q1 | $8.01M | Buy |
|
|||||
|
2024
Q4 | $1.67M | Buy |
|
|||||
|
2024
Q3 | $677K | Sell |
|
|||||
|
2024
Q2 | $4.13M | Buy |
|
|||||
|
2024
Q1 | $2.79M | Sell |
|
|||||
|
2023
Q4 | $2.93M | Sell |
|
|||||
|
2023
Q3 | $6.64M | Buy |
|
|||||
|
2023
Q2 | $9.21M | Buy |
|
|||||
|
2023
Q1 | $730K | Sell |
|
|||||
|
2022
Q4 | $1.62M | Buy |
|
|||||
|
2022
Q3 | $1.9M | Sell |
|
|||||
|
2022
Q2 | $2.34M | Buy |
|
|||||
|
2022
Q1 | $211K | Sell |
|
|||||
|
2021
Q4 | $8.4M | Sell |
|
|||||
|
2021
Q3 | $6.07M | Buy |
|
|||||
|
2021
Q2 | $1.58M | Buy |
|
|||||
|
2021
Q1 | $764K | Buy |
|
|||||
|
2020
Q4 | $157K | Sell |
|
|||||
|
2020
Q3 | $1.05M | Buy |
|
|||||
|
2020
Q2 | $158K | Sell |
|
|||||
|
2020
Q1 | $309K | Buy |
|
|||||
|
2019
Q4 | $264K | Sell |
|
|||||
|
2019
Q3 | $1.58M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $112K | Buy |
|